A ground-breaking Cure Parkinson’s supported study that involved screening over 230,000 molecules has identified farnesol, a commonly found aromatic oil, as a new potential treatment of Parkinson’s.
Inhibikase Therapeutics has designed a novel drug that is similar to the drug nilotinib – previously tested in people with Parkinson’s – but is better at reaching its target in the brain.
On 27 October, 50 long-time supporters of Cure Parkinson’s gathered at Micklefield Hall in Sarratt, Hertfordshire for the launch of our legacy campaign, Planting for a Cure.
On Thursday 14 October, 54 players enjoyed a round of golf in memory of Cure Parkinson’s late Co-founder and President, Tom Isaacs, raising over £2,000 for Parkinson’s research. The annual Tom Isaacs Memorial Golf Day, kindly hosted each year by Denham Golf Club, is one…
Meriel Buxton, our 2020 Fundraiser of the Year, has received Prime Minister Boris Johnson’s Points of Light award.